Reimbursement In Brief

CMS’ 2014 draft hospital outpatient prospective payment system proposes cuts to CT and MRI and increases for radiation therapy. OIG recommends New York Medicaid set competitive bidding program for test strips. More reimbursement news.

CMS is proposing cutting reimbursements for CT and MRI scans by about 30 percent and 20 percent, respectively, in the agency’s 2014 hospital outpatient prospective payment proposed rule, issued July 8. CMS has been collecting data on distinct cost centers for cardiac catheterizations, CT scans and MRI scans since FY 2011, but is deciding for the first time to apply these cost centers in FY 2014 to calculate reimbursement payments. Imaging groups have opposed the CMS’ plans to apply the new cost centers’ data to the 2014 inpatient hospital proposed rule. (See Also see "Device Firms Oppose New Imaging Cost Centers For 2014 Medicare Payments" - Medtech Insight, 5 July, 2013..)

CMS is proposing increasing reimbursement for radiation therapy in the 2014 outpatient payment proposed rule. In particular, reimbursement for certain intensity modulated radiation therapy services would increase by 130 percent....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Policy & Regulation

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By 

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.